U.S. Representatives Alexandria Ocasio-Cortez and Jan Schakowsky, joined by 20 Democratic colleagues, expressed concerns over consumer data privacy in letters to the potential buyers of genetic testing firm 23andMe, namely Regeneron Pharmaceuticals and TTAM Research Institute. They inquired about the companies' plans regarding customer data retention and sharing practices, amid a backdrop of 23andMe's bankruptcy and potential ownership transfer. Regeneron had proposed a $256 million bid, but TTAM countered with $305 million through a nonprofit setup, leading a federal judge to revisit the sales process. The fate of user data practices hangs in the balance during this transition.
In letters to Regeneron and TTAM, Congress members emphasized the need for consumer data privacy assurance amid 23andMe's potential acquisition, urging both companies to uphold existing policies.
After facing financial difficulties and filing for bankruptcy, 23andMe is now caught in a bidding war between Regeneron and TTAM, raising concerns over user data privacy.
Collection
[
|
...
]